The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited.
Journal: Movement disorders : official journal of the Movement Disorder Society
Volume: 37
Issue: 9
Year of Publication: 2022
Affiliated Institutions:
Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Team "Exposome, Heredity, Cancer, and Health", CESP, Villejuif, France.
Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, Nantes, France.
Centre for Genetic Epidemiology, Institute for Clinical Epidemiology, and Applied Biometry, University of Tubingen, Tübingen, Germany.
Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tubingen, Tübingen, Germany.
Translational Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Molecular Genetics Section, Laboratory of Neurogenetics, NIA, NIH, Bethesda, Maryland, USA.
Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia.
Department of Neurology, Medical University of Vienna, Wien, Austria.
Department of Neurology, Klinik Ottakring, Vienna, Austria.
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Murdoch, Australia.
Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.
Department of Neurologie, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, Assistance Publique Hôpitaux de Paris, Paris, France.
Univ. Lille, Inserm, CHU Lille, UMR-S - LilNCog- Centre de Recherche Lille Neurosciences and Cognition, Lille, France.
Department of Neurology, Ludwig Maximilians University of Munich, Munich, Germany.
Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece.
st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Department of Molecular Medicine, University of Pavia, Pavia, Italy.
UOC Medical Genetics and Advanced Cell Diagnostics, S. Andrea University Hospital, Rome, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Parkinson Institute, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini/CTO, Milan, Italy.
Parkinson Institute, Fontazione Grigioni, Milan, Italy.
Department of Neurology, San Gerardo Hospital, Monza, Italy.
Institute for Biomedical Research and Innovation, National Research Council, Cosenza, Italy.
Institute of Neurology, Magna Graecia University, Catanzaro, Italy.
Institute of Molecular Bioimaging and Physiology National Research Council, Catanzaro, Italy.
Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Saitama, Japan.
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
Neurology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Department of Neurology, St Olav's Hospital and Norwegian University of Science and Technology, Trondheim, Norway.
Department of Neurology, Oslo University Hospital, Oslo, Norway.
Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Division of Neurology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Lab of Parkinson Disease and Other Neurodegenerative Movement Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Institut de Neurociències, Universitat de Barcelona, Barcelona, Catalonia, Spain.
Fundació per la Recerca Biomèdica i Social Mútua Terrassa, Barcelona, Spain.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Sciences Lund, Neurology, Lund University, Skåne University Hospital, Lund, Sweden.
University of Birmingham and Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom.
Faculty of Medicine, Health and Life Sciences, Queens University, Belfast, United Kingdom.
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.